Although lymph node metastasis is an indicator of poor prognosis of patients with breast carcinomas [35], a long-term follow-up is warranted to clarify whether derlin-1 expression is associated with the outcome in breast cancer, especially in lymph node-negative breast cancer. This evidence concerns the gene DERL1 and breast carcinoma.